1797:HKEXEast Buy Holding Limited Analysis
Data as of 2026-05-24 - not real-time
HK$22.78
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
East Buy Holding Limited is trading below its long‑term moving average while technical momentum indicators such as the relative strength index suggest the stock is in oversold territory. Macd remains in a bearish configuration and the market price is hovering near a key support level, which adds short‑term downside pressure despite a neutral overall trend. The security exhibits elevated short‑term volatility yet its beta indicates a muted correlation to broader market moves, implying that price swings are driven more by company‑specific factors than market sentiment.
Fundamentally, the company boasts a robust cash position, minimal debt, and modest revenue growth, but valuation multiples are markedly high relative to its discounted cash‑flow estimate and earnings forecasts. Analyst price targets imply a material upside, though the lack of a dividend and a high price‑to‑earnings multiple raise concerns about value. In this context, the stock appears overvalued on a valuation basis while still offering potential upside if earnings improve and market sentiment shifts.
Fundamentally, the company boasts a robust cash position, minimal debt, and modest revenue growth, but valuation multiples are markedly high relative to its discounted cash‑flow estimate and earnings forecasts. Analyst price targets imply a material upside, though the lack of a dividend and a high price‑to‑earnings multiple raise concerns about value. In this context, the stock appears overvalued on a valuation basis while still offering potential upside if earnings improve and market sentiment shifts.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical oversold signals with price near support
- Bearish macd momentum
- Elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst price targets suggest upside
- Strong cash generation and low debt
- Improving forward earnings outlook
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable cash flows but high valuation
- Potential regulatory headwinds in core markets
- Stable sector positioning within consumer defensive
Key Metrics & Analysis
Financial Health
Revenue Growth5.70%
Profit Margin7.56%
P/E Ratio61.6
ROE6.59%
ROA3.31%
Debt/Equity0.63
P/B Ratio3.8
Op. Cash FlowHK$537.9M
Free Cash FlowHK$472.1M
Technical Analysis
TrendNeutral
RSI32.8
SupportHK$22.52
ResistanceHK$28.88
MA 20HK$25.67
MA 50HK$26.72
MA 200HK$24.65
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair ValueHK$12.46
Target PriceHK$29.19
Upside/Downside28.13%
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.57
Volatility48.22%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.